MIG was founded as the management company of MIG Fonds in 2004. In 2014, MIG became an authorized AIF Manager through permission in accordance with §§ 20, 22 KAGB (German Capital Investment Act). The investment funds managed by MIG AG invest in start-up businesses in high-tech sectors of various industries: biotechnology, medical devices, material and clean technology, information technology and automation engineering.
MIG is headquartered in Munchen, Germany and was founded Jürgen Kosch and Michael Motschmann.
According to the company's website (as of November 2019) they have invested over 500 million Euros in over 30 startups, and has 23 companies in its portfolio. The firm focuses investing in technology companies operating in the sectors of biotechnology, medical devices, material, clean technology, information technology, and automation engineering. Notable investments made by MIG Verwaltungs AG include: BioNTech, IQM, NFON Cloud Telephone System, Liva Healthcare, NavVis, GWA Hygiene, KEWAZO, Cynora, and Ganymed.
Company utilizing superconducting technology to build scalable quantum computing hardware.
A synthetic biology company that produces fibers made from the same protein as spider silk.
Konux provides operation automation solutions based on machine learning and IoT for the railway industry.
AdvanceCOR is a Planegg-based company developing drugs and diagnostics for the treatment of cardiovascular diseases founded in 2012 by Martin Lohse.
Indoor Spatial Intelligence Technology and Enterprise Solutions company based in Munich, Germany.
German Bionic is a robotics company focused on developing and building exoskeletons for use in industrial production.
SuppreMol is a company in the pharmaceuticals industry.
Protagen is a company in the pharmaceuticals industry.